Here are four points:
1. The study examines the safety and efficacy of InVivo Therapeutics’ Neuro-Spinal Scaffold in patients suffering from complete, thoracic spinal cord injury.
2. The patient has been enrolled at the Barnes-Jewish Hospital at Washington University Medical Center in St. Louis, which serves as a site of the study.
3. Wilson Ray, MD, an associate professor of neurosurgery and a member of The INSPIRE Study Steering Committee, implanted the scaffold in the patient.
4. The biodegradable Neuro-Spinal Scaffold is an investigational device that has received a ‘humanitarian use device’ designation from the FDA.
More articles on devices:
26 spine devices receive FDA 510(k) clearance in January
Medtronic, Stryker, Zimmer Biomet, DePuy Synthes, Smith & Nephew: Who had the best 2015? 32 things to know
Cervical artificial disc replacement & lateral spine surgery: 6 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
